Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0031019 | mitochondrial mRNA editing complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0045293 | mRNA editing complex | 3 | 2 |
GO:0098798 | mitochondrial protein-containing complex | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:1902494 | catalytic complex | 2 | 2 |
Related structures:
AlphaFold database: Q4QIH9
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009451 | RNA modification | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0010035 | response to inorganic substance | 3 | 2 |
GO:0010038 | response to metal ion | 4 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016071 | mRNA metabolic process | 6 | 2 |
GO:0016556 | mRNA modification | 6 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0042221 | response to chemical | 2 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0050896 | response to stimulus | 1 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000175 | 3'-5'-RNA exonuclease activity | 7 | 2 |
GO:0003824 | catalytic activity | 1 | 2 |
GO:0004518 | nuclease activity | 4 | 2 |
GO:0004519 | endonuclease activity | 5 | 2 |
GO:0004521 | RNA endonuclease activity | 5 | 2 |
GO:0004527 | exonuclease activity | 5 | 2 |
GO:0004532 | RNA exonuclease activity | 5 | 2 |
GO:0004540 | RNA nuclease activity | 4 | 2 |
GO:0005488 | binding | 1 | 4 |
GO:0008270 | zinc ion binding | 6 | 2 |
GO:0008408 | 3'-5' exonuclease activity | 6 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 2 |
GO:0016891 | RNA endonuclease activity, producing 5'-phosphomonoesters | 6 | 2 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 2 |
GO:0016896 | RNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 2 |
GO:0043167 | ion binding | 2 | 2 |
GO:0043169 | cation binding | 3 | 2 |
GO:0046872 | metal ion binding | 4 | 2 |
GO:0046914 | transition metal ion binding | 5 | 2 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 2 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 2 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003677 | DNA binding | 4 | 2 |
GO:0003697 | single-stranded DNA binding | 5 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 255 | 259 | PF00656 | 0.769 |
CLV_NRD_NRD_1 | 55 | 57 | PF00675 | 0.628 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.603 |
CLV_PCSK_FUR_1 | 264 | 268 | PF00082 | 0.574 |
CLV_PCSK_KEX2_1 | 266 | 268 | PF00082 | 0.612 |
CLV_PCSK_KEX2_1 | 55 | 57 | PF00082 | 0.606 |
CLV_PCSK_KEX2_1 | 64 | 66 | PF00082 | 0.586 |
CLV_PCSK_PC1ET2_1 | 266 | 268 | PF00082 | 0.612 |
CLV_PCSK_SKI1_1 | 266 | 270 | PF00082 | 0.533 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.690 |
DEG_SPOP_SBC_1 | 168 | 172 | PF00917 | 0.717 |
DEG_SPOP_SBC_1 | 189 | 193 | PF00917 | 0.747 |
DEG_SPOP_SBC_1 | 221 | 225 | PF00917 | 0.757 |
DOC_CKS1_1 | 320 | 325 | PF01111 | 0.682 |
DOC_CKS1_1 | 428 | 433 | PF01111 | 0.539 |
DOC_CYCLIN_RxL_1 | 35 | 46 | PF00134 | 0.459 |
DOC_CYCLIN_yCln2_LP_2 | 235 | 241 | PF00134 | 0.589 |
DOC_CYCLIN_yCln2_LP_2 | 42 | 45 | PF00134 | 0.455 |
DOC_MAPK_gen_1 | 148 | 156 | PF00069 | 0.689 |
DOC_MAPK_MEF2A_6 | 395 | 403 | PF00069 | 0.540 |
DOC_MAPK_MEF2A_6 | 482 | 491 | PF00069 | 0.383 |
DOC_PP2B_LxvP_1 | 235 | 238 | PF13499 | 0.589 |
DOC_PP2B_LxvP_1 | 42 | 45 | PF13499 | 0.455 |
DOC_PP2B_PxIxI_1 | 486 | 492 | PF00149 | 0.383 |
DOC_PP4_FxxP_1 | 207 | 210 | PF00568 | 0.657 |
DOC_PP4_FxxP_1 | 428 | 431 | PF00568 | 0.467 |
DOC_PP4_FxxP_1 | 450 | 453 | PF00568 | 0.518 |
DOC_SPAK_OSR1_1 | 463 | 467 | PF12202 | 0.414 |
DOC_USP7_MATH_1 | 176 | 180 | PF00917 | 0.633 |
DOC_USP7_MATH_1 | 188 | 192 | PF00917 | 0.567 |
DOC_USP7_MATH_1 | 214 | 218 | PF00917 | 0.719 |
DOC_USP7_MATH_1 | 222 | 226 | PF00917 | 0.726 |
DOC_USP7_MATH_1 | 318 | 322 | PF00917 | 0.700 |
DOC_USP7_MATH_1 | 352 | 356 | PF00917 | 0.620 |
DOC_USP7_UBL2_3 | 144 | 148 | PF12436 | 0.591 |
DOC_WW_Pin1_4 | 179 | 184 | PF00397 | 0.667 |
DOC_WW_Pin1_4 | 190 | 195 | PF00397 | 0.692 |
DOC_WW_Pin1_4 | 198 | 203 | PF00397 | 0.550 |
DOC_WW_Pin1_4 | 223 | 228 | PF00397 | 0.719 |
DOC_WW_Pin1_4 | 299 | 304 | PF00397 | 0.742 |
DOC_WW_Pin1_4 | 319 | 324 | PF00397 | 0.722 |
DOC_WW_Pin1_4 | 427 | 432 | PF00397 | 0.438 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.665 |
LIG_14-3-3_CanoR_1 | 103 | 111 | PF00244 | 0.616 |
LIG_14-3-3_CanoR_1 | 33 | 42 | PF00244 | 0.465 |
LIG_14-3-3_CanoR_1 | 65 | 73 | PF00244 | 0.688 |
LIG_CaM_IQ_9 | 271 | 287 | PF13499 | 0.453 |
LIG_Clathr_ClatBox_1 | 153 | 157 | PF01394 | 0.678 |
LIG_EVH1_2 | 44 | 48 | PF00568 | 0.469 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.525 |
LIG_FHA_1 | 156 | 162 | PF00498 | 0.703 |
LIG_FHA_1 | 275 | 281 | PF00498 | 0.455 |
LIG_FHA_1 | 440 | 446 | PF00498 | 0.386 |
LIG_FHA_1 | 465 | 471 | PF00498 | 0.399 |
LIG_FHA_1 | 493 | 499 | PF00498 | 0.389 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.610 |
LIG_FHA_2 | 320 | 326 | PF00498 | 0.714 |
LIG_LIR_Apic_2 | 426 | 431 | PF02991 | 0.456 |
LIG_LIR_Apic_2 | 449 | 453 | PF02991 | 0.520 |
LIG_LIR_Gen_1 | 437 | 446 | PF02991 | 0.406 |
LIG_LIR_Nem_3 | 124 | 128 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 437 | 443 | PF02991 | 0.423 |
LIG_LIR_Nem_3 | 449 | 454 | PF02991 | 0.326 |
LIG_LYPXL_yS_3 | 486 | 489 | PF13949 | 0.387 |
LIG_MYND_1 | 45 | 49 | PF01753 | 0.465 |
LIG_PDZ_Class_2 | 496 | 501 | PF00595 | 0.414 |
LIG_Pex14_2 | 203 | 207 | PF04695 | 0.689 |
LIG_SH2_CRK | 15 | 19 | PF00017 | 0.461 |
LIG_SH2_CRK | 4 | 8 | PF00017 | 0.457 |
LIG_SH2_CRK | 484 | 488 | PF00017 | 0.390 |
LIG_SH2_STAT3 | 362 | 365 | PF00017 | 0.710 |
LIG_SH2_STAT5 | 362 | 365 | PF00017 | 0.589 |
LIG_SH2_STAT5 | 413 | 416 | PF00017 | 0.459 |
LIG_SH3_3 | 317 | 323 | PF00018 | 0.788 |
LIG_SH3_3 | 368 | 374 | PF00018 | 0.519 |
LIG_SH3_3 | 379 | 385 | PF00018 | 0.495 |
LIG_SH3_3 | 430 | 436 | PF00018 | 0.459 |
LIG_TRAF2_1 | 260 | 263 | PF00917 | 0.723 |
LIG_TRAF2_1 | 384 | 387 | PF00917 | 0.480 |
LIG_TYR_ITIM | 13 | 18 | PF00017 | 0.462 |
MOD_CDK_SPxxK_3 | 299 | 306 | PF00069 | 0.556 |
MOD_CK1_1 | 169 | 175 | PF00069 | 0.640 |
MOD_CK1_1 | 179 | 185 | PF00069 | 0.663 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.707 |
MOD_CK1_1 | 223 | 229 | PF00069 | 0.745 |
MOD_CK1_1 | 299 | 305 | PF00069 | 0.631 |
MOD_CK1_1 | 319 | 325 | PF00069 | 0.693 |
MOD_CK1_1 | 83 | 89 | PF00069 | 0.708 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.732 |
MOD_CK2_1 | 319 | 325 | PF00069 | 0.761 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.676 |
MOD_GlcNHglycan | 195 | 198 | PF01048 | 0.627 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.666 |
MOD_GlcNHglycan | 298 | 301 | PF01048 | 0.630 |
MOD_GlcNHglycan | 303 | 306 | PF01048 | 0.620 |
MOD_GlcNHglycan | 332 | 335 | PF01048 | 0.749 |
MOD_GlcNHglycan | 459 | 462 | PF01048 | 0.538 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.512 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.544 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.721 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.630 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.740 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.506 |
MOD_GSK3_1 | 223 | 230 | PF00069 | 0.663 |
MOD_GSK3_1 | 243 | 250 | PF00069 | 0.667 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.479 |
MOD_GSK3_1 | 295 | 302 | PF00069 | 0.574 |
MOD_GSK3_1 | 423 | 430 | PF00069 | 0.528 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.601 |
MOD_LATS_1 | 31 | 37 | PF00433 | 0.467 |
MOD_N-GLC_1 | 252 | 257 | PF02516 | 0.685 |
MOD_N-GLC_1 | 352 | 357 | PF02516 | 0.665 |
MOD_N-GLC_2 | 398 | 400 | PF02516 | 0.403 |
MOD_NEK2_1 | 269 | 274 | PF00069 | 0.453 |
MOD_NEK2_1 | 420 | 425 | PF00069 | 0.456 |
MOD_NEK2_1 | 464 | 469 | PF00069 | 0.391 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.462 |
MOD_NEK2_2 | 121 | 126 | PF00069 | 0.521 |
MOD_NEK2_2 | 274 | 279 | PF00069 | 0.452 |
MOD_PIKK_1 | 35 | 41 | PF00454 | 0.462 |
MOD_PIKK_1 | 475 | 481 | PF00454 | 0.557 |
MOD_PKA_2 | 102 | 108 | PF00069 | 0.688 |
MOD_Plk_1 | 352 | 358 | PF00069 | 0.662 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.507 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.668 |
MOD_ProDKin_1 | 179 | 185 | PF00069 | 0.667 |
MOD_ProDKin_1 | 190 | 196 | PF00069 | 0.691 |
MOD_ProDKin_1 | 198 | 204 | PF00069 | 0.543 |
MOD_ProDKin_1 | 223 | 229 | PF00069 | 0.721 |
MOD_ProDKin_1 | 299 | 305 | PF00069 | 0.742 |
MOD_ProDKin_1 | 319 | 325 | PF00069 | 0.724 |
MOD_ProDKin_1 | 427 | 433 | PF00069 | 0.442 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.665 |
TRG_DiLeu_BaEn_2 | 264 | 270 | PF01217 | 0.663 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.468 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.458 |
TRG_ENDOCYTIC_2 | 486 | 489 | PF00928 | 0.387 |
TRG_ER_diArg_1 | 10 | 13 | PF00400 | 0.491 |
TRG_ER_diArg_1 | 54 | 56 | PF00400 | 0.628 |
TRG_ER_diArg_1 | 64 | 66 | PF00400 | 0.599 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1P1 | Leptomonas seymouri | 57% | 100% |
A0A0S4IKI2 | Bodo saltans | 45% | 100% |
A0A1X0NPK8 | Trypanosomatidae | 48% | 100% |
A0A3S5H616 | Leishmania donovani | 90% | 100% |
A0A422N9Y4 | Trypanosoma rangeli | 46% | 100% |
A4H556 | Leishmania braziliensis | 73% | 100% |
A4HTD3 | Leishmania infantum | 93% | 100% |
C9ZUI1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
E9ALC6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
V5DQ35 | Trypanosoma cruzi | 47% | 100% |